JASON CAPLAN: Open Payments
NPI 1538196456 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$118,396 in 127 payments from 3 companies in 2025. Trend: 2023 $104,209 · 2024 $123,249 · 2025 $118,396
Speaker / faculty: $79,655Consulting: $23,465Travel & lodging: $12,968Food & beverage: $2,308
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 65 | $57,975 |
| E.R. Squibb & Sons, L.L.C. | 35 | $38,337 |
| Otsuka America Pharmaceutical, Inc. | 27 | $22,084 |
Products named: INGREZZA, COBENFY, REXULTI.
Industry payments across AZ — which companies pay providers there.
